Jiangsu Bioperfectus Technologies Co., Ltd. (SHA:688399)
67.51
-0.09 (-0.13%)
At close: Feb 13, 2026
SHA:688399 Market Cap
SHA:688399 has a market cap or net worth of 5.66 billion as of February 13, 2026. Its market cap has increased by 57.77% in one year.
Market Cap
5.66B
Enterprise Value
4.46B
Revenue
339.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
67.51
Market Cap Chart
Since December 5, 2019, SHA:688399's market cap has increased from 3.22B to 5.66B, an increase of 76.00%. That is a compound annual growth rate of 9.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 5.66B | -1.45% |
| Dec 31, 2025 | 5.75B | 54.17% |
| Dec 31, 2024 | 3.73B | 16.52% |
| Dec 29, 2023 | 3.20B | -37.80% |
| Dec 30, 2022 | 5.14B | -36.21% |
| Dec 31, 2021 | 8.06B | -28.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Weiguang Biological Products | 6.46B |
| PharmaResources (Shanghai) | 6.35B |
| Novogene | 6.31B |
| Xiangxue Pharmaceutical | 6.21B |
| Kexing Biopharm | 6.17B |
| Shouyao Holdings (Beijing) Co., LTD. | 6.04B |
| ChemPartner PharmaTech | 5.62B |
| Lifecome Biochemistry | 5.57B |